Third International Conference on Cancer and the Adolescent

December 20, 2003

For updated information, click here.

Royal College of Physicians, 11 St Andrews Place, London NW1 4LE
Monday 1 March - Tuesday 2 March 2004

You are invited to attend the only conference in the world on cancer and the adolescent. It is organised by the Teenage Cancer Trust, the pioneering UK charity that was established to focus on the most neglected group of cancer patients - teenagers and young adults. The UK, through the Trust, is the sole country in the world to have a programme of developing specialist units for adolescents. There are now 8 and the target is at least 20 across Britain, which will give every teenager access to a dedicated unit. Other countries are now beginning to follow the UK's lead.

Leading international specialists from Europe and America will present new research findings to the conference on incidence, risk, causes, treatment, supportive care and psychological effects. They will discuss and debate some of the controversial areas that impact on young patients such as body image, future fertility, the effect on families, careers......

Speakers will also include patients like paralympic gold medallist Marc Woods, who will explain what it is like to have been one of this 'Cinderella' age group and how they have fought back to lead full and active lives.

Registration is free for bona fide UK and international media. You are welcome to attend all conference sessions. There will be a news briefing on the opening morning with key speakers and patients.

For more information on the Trust, visit its web site at:

A media conference registration form and conference programme is available from: TCT press officer Lucy Shure: Tel: +44(0) 207 387 1000 Email: or TCT media consultant Margaret Willson: Tel: +44(0)1536 772181 Email:

Early media registration is strongly recommended, as places at the conference are limited.

Teenage Cancer Trust

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to